Corifollitropin alfa: Phase III data

In the double-blind, international Phase III ENGAGE trial in 1,509 women, 150 µg of corifollitropin alfa met the primary endpoint of an ongoing pregnancy rate that was non-inferior to 200 IU of Folli...